Lung Stent Industry: New Market Insights Recent Developments, Current Landscape, and Future Prospects in Stent Industry


Posted June 3, 2024 by ashwinicmi

Lung stents are tiny mesh tubes placed inside the airways of the lungs to keep them open. They are typically made of metal or silicone and are inserted using a bronchoscope, a thin, flexible tube passed through the mouth or nose into the lungs.
 
Stents are used to treat conditions that cause the airways to narrow or collapse, such as lung cancer, tuberculosis, or other diseases. Keeping the airways open with stents helps improve breathing and quality of life.

Types of Lung Stent Industry

There are different types of lung stents available depending on where they are placed and what they are made of:

- Tracheobronchial Stents: Global Lung Stent These are the most common type used to keep the large airways like the trachea and main bronchi open. They are cylindrical in shape and available in various sizes. Metallic models like nitinol and silicone stents are frequently utilized.

- Bronchial Stents: Similar in design to tracheal stents, bronchial stents are smaller and used to treat narrowed bronchi further inside the lungs. Both removable and non-removable options exist.

- Uncovered/Covered Stents: Uncovered stents have a bare metallic structure while covered stents have a silicone covering over the metal. Covered versions are preferred for conditions like cancer to prevent tissue ingrowth.

- Removable/Non-removable Stents: Removable stents can be taken out using a bronchoscope if no longer needed. Non-removable stents permanently remain in place.

Key Factors Driving Demand for Lung Stents

Rising Prevalence of Lung Diseases: The increasing incidence of chronic respiratory illnesses globally due to pollution, tobacco use, and aging populations is a primary driver for the lung stent industry. Diseases that can benefit from airway stenting include lung cancer, COPD, and tuberculosis.

Technological Advancements: New stent designs with improved biocompatibility, delivery techniques, and ability to treat complex cases have expanded the clinical applications of these devices. Drug-eluting and bioresorbable stents are areas of active research.

Growth of Geriatric Population: Older adults are more prone to developing lung conditions like lung cancer. Since life expectancy is rising worldwide, the prevalence of such age-related illnesses is projected to surge the demand for stents used in therapeutic and palliative care.

Increasing Healthcare Expenditure: Rising disposable incomes in developing nations have enhanced the accessibility of sophisticated treatments. Government initiatives and greater health insurance penetration are also boosting spending on medical devices and technologies in these markets.

Regional Market Analysis

North America currently dominates the global lung stent space owing to favorable reimbursement scenarios and a large patient population affected by respiratory disorders. However, the market in Asia Pacific is growing at an impressive pace driven by the unmet clinical needs, growing healthcare infrastructure, and large patient pools in China and India. Meanwhile, Europe is another major regional sector supported by high research funding and manufacturing activity across Germany, France, and the UK.

Key Market Players

Some of the leading companies operating in the worldwide lung stent marketplace are Boston Scientific Corporation, Cook Medical, E. Benson Hood Laboratories, Merit Medical Systems, Novatech SA, Taewoong Medical, Micro-Tech (Nanjing), Boston Medical Products, C.R. Bard, and Cantel Medical. These players are focusing on new product launches, mergers and acquisitions for portfolio expansion, and geographical expansions to consolidate their industry presence.

In summary, the global lung stent market is projected to experience steady growth in the coming years supported by the escalating cancer incidence, aging demographics, and improving accessibility of novel stents. While developed nations will continue dominating sales, developing Asian and Latin American countries present lucrative prospects. Moreover, ongoing research into bioresorbable stents holding promise for long-term outcomes further augurs well for industry prospects. Increased healthcare investments and expanding clinical applications of these lifesaving devices across the world are other major factors that will positively impact the market remuneration.

Get more insights on This Topic- Global Lung Stent
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By cmi
Business Address 1001 4th Ave Ste 3200
Country India
Categories Business
Tags medical care , world health organization , chronic obstructive pulmonary disease
Last Updated June 3, 2024